Global Hemato Oncology Testing Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Hemato Oncology Testing Market Overview

• 1.1 Product Overview and Scope of Hemato Oncology Testing
• 1.2 Classification of Hemato Oncology Testing by Types
  • 1.2.1 Global Hemato Oncology Testing Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Hemato Oncology Testing Revenue Market Share by Types in 2018
  • 1.2.3 Leukemia Testing
  • 1.2.4 Acute Myeloid Testing
  • 1.2.5 Multiple Myeloma Testing
  • 1.2.6 Other
• 1.3 Global Hemato Oncology Testing Market by Application
  • 1.3.1 Global Hemato Oncology Testing Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Clinical Laboratories
  • 1.3.3 Hospitals
• 1.4 Global Hemato Oncology Testing Market by Regions
  • 1.4.1 Global Hemato Oncology Testing Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Hemato Oncology Testing Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Hemato Oncology Testing Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hemato Oncology Testing Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Hemato Oncology Testing Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hemato Oncology Testing Status and Prospect (2014-2024)
• 1.5 Global Market Size of Hemato Oncology Testing (2014-2024)

2 Company Profiles

• 2.1 MolecularMD
  • 2.1.1 Business Overview
  • 2.1.2 Hemato Oncology Testing Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 MolecularMD Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Invivoscribe
  • 2.2.1 Business Overview
  • 2.2.2 Hemato Oncology Testing Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Invivoscribe Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 QIAGEN N.V.
  • 2.3.1 Business Overview
  • 2.3.2 Hemato Oncology Testing Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 QIAGEN N.V. Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Abbott Laboratories
  • 2.4.1 Business Overview
  • 2.4.2 Hemato Oncology Testing Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Abbott Laboratories Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 F. Hoffmann-La Roche
  • 2.5.1 Business Overview
  • 2.5.2 Hemato Oncology Testing Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 F. Hoffmann-La Roche Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Thermo Fisher Scientific
  • 2.6.1 Business Overview
  • 2.6.2 Hemato Oncology Testing Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Thermo Fisher Scientific Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Adaptive Biotechnologies
  • 2.7.1 Business Overview
  • 2.7.2 Hemato Oncology Testing Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Adaptive Biotechnologies Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Illumina
  • 2.8.1 Business Overview
  • 2.8.2 Hemato Oncology Testing Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Illumina Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Bio-Rad Laboratories
  • 2.9.1 Business Overview
  • 2.9.2 Hemato Oncology Testing Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Bio-Rad Laboratories Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Asuragen
  • 2.10.1 Business Overview
  • 2.10.2 Hemato Oncology Testing Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Asuragen Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 ArcherDx
  • 2.11.1 Business Overview
  • 2.11.2 Hemato Oncology Testing Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 ArcherDx Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 ARUP Laboratories
  • 2.12.1 Business Overview
  • 2.12.2 Hemato Oncology Testing Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 ARUP Laboratories Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2018)

3 Global Hemato Oncology Testing Market Competition, by Players

• 3.1 Global Hemato Oncology Testing Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Hemato Oncology Testing Players Market Share
  • 3.2.2 Top 10 Hemato Oncology Testing Players Market Share
• 3.3 Market Competition Trend

4 Global Hemato Oncology Testing Market Size by Regions

• 4.1 Global Hemato Oncology Testing Revenue and Market Share by Regions
• 4.2 North America Hemato Oncology Testing Revenue and Growth Rate (2014-2019)
• 4.3 Europe Hemato Oncology Testing Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Hemato Oncology Testing Revenue and Growth Rate (2014-2019)
• 4.5 South America Hemato Oncology Testing Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Hemato Oncology Testing Revenue and Growth Rate (2014-2019)

5 North America Hemato Oncology Testing Revenue by Countries

• 5.1 North America Hemato Oncology Testing Revenue by Countries (2014-2019)
• 5.2 USA Hemato Oncology Testing Revenue and Growth Rate (2014-2019)
• 5.3 Canada Hemato Oncology Testing Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Hemato Oncology Testing Revenue and Growth Rate (2014-2019)

6 Europe Hemato Oncology Testing Revenue by Countries

• 6.1 Europe Hemato Oncology Testing Revenue by Countries (2014-2019)
• 6.2 Germany Hemato Oncology Testing Revenue and Growth Rate (2014-2019)
• 6.3 UK Hemato Oncology Testing Revenue and Growth Rate (2014-2019)
• 6.4 France Hemato Oncology Testing Revenue and Growth Rate (2014-2019)
• 6.5 Russia Hemato Oncology Testing Revenue and Growth Rate (2014-2019)
• 6.6 Italy Hemato Oncology Testing Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Hemato Oncology Testing Revenue by Countries

• 7.1 Asia-Pacific Hemato Oncology Testing Revenue by Countries (2014-2019)
• 7.2 China Hemato Oncology Testing Revenue and Growth Rate (2014-2019)
• 7.3 Japan Hemato Oncology Testing Revenue and Growth Rate (2014-2019)
• 7.4 Korea Hemato Oncology Testing Revenue and Growth Rate (2014-2019)
• 7.5 India Hemato Oncology Testing Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Hemato Oncology Testing Revenue and Growth Rate (2014-2019)

8 South America Hemato Oncology Testing Revenue by Countries

• 8.1 South America Hemato Oncology Testing Revenue by Countries (2014-2019)
• 8.2 Brazil Hemato Oncology Testing Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Hemato Oncology Testing Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Hemato Oncology Testing Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Hemato Oncology Testing by Countries

• 9.1 Middle East and Africa Hemato Oncology Testing Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Hemato Oncology Testing Revenue and Growth Rate (2014-2019)
• 9.3 UAE Hemato Oncology Testing Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Hemato Oncology Testing Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Hemato Oncology Testing Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Hemato Oncology Testing Revenue and Growth Rate (2014-2019)

10 Global Hemato Oncology Testing Market Segment by Type

• 10.1 Global Hemato Oncology Testing Revenue and Market Share by Type (2014-2019)
• 10.2 Global Hemato Oncology Testing Market Forecast by Type (2019-2024)
• 10.3 Leukemia Testing Revenue Growth Rate (2014-2024)
• 10.4 Acute Myeloid Testing Revenue Growth Rate (2014-2024)
• 10.5 Multiple Myeloma Testing Revenue Growth Rate (2014-2024)
• 10.6 Other Revenue Growth Rate (2014-2024)

11 Global Hemato Oncology Testing Market Segment by Application

• 11.1 Global Hemato Oncology Testing Revenue Market Share by Application (2014-2019)
• 11.2 Hemato Oncology Testing Market Forecast by Application (2019-2024)
• 11.3 Clinical Laboratories Revenue Growth (2014-2019)
• 11.4 Hospitals Revenue Growth (2014-2019)

12 Global Hemato Oncology Testing Market Size Forecast (2019-2024)

• 12.1 Global Hemato Oncology Testing Market Size Forecast (2019-2024)
• 12.2 Global Hemato Oncology Testing Market Forecast by Regions (2019-2024)
• 12.3 North America Hemato Oncology Testing Revenue Market Forecast (2019-2024)
• 12.4 Europe Hemato Oncology Testing Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Hemato Oncology Testing Revenue Market Forecast (2019-2024)
• 12.6 South America Hemato Oncology Testing Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Hemato Oncology Testing Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology